Sterile Plant-Based Gauze for Eyelid Hygiene in Anterior Blepharitis
NCT07759180 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38
Last updated 2026-08-12
Summary
The goal of this clinical trial is to learn whether a sterile gauze containing natural plant extracts can lower the number of bacteria on the eyelid margin in people with bilateral anterior blepharitis. The study will also evaluate whether the product is safe and well tolerated after a single application.
The main questions it aims to answer are:
* Does the sterile gauze containing natural plant extracts reduce the bacterial load on the eyelid margin more than a standard sterile gauze?
* Does the treatment improve eyelid comfort without causing unwanted side effects?
Researchers will compare the study gauze with a sterile gauze without active ingredients. Each participant will receive both treatments: the right eye will be treated with the study gauze, while the left eye will be treated with the control gauze. This allows each participant to serve as their own control.
Participants will:
* Attend one study visit.
* Undergo an eye examination to confirm the diagnosis of bilateral anterior blepharitis.
* Have samples collected from the upper and lower eyelid margins of both eyes before treatment.
* Receive eyelid cleansing with the assigned gauze for each eye.
* Have eyelid samples collected again 20 minutes after treatment.
* Complete a short questionnaire about treatment comfort and tolerability.
The study will compare the change in bacterial growth between the two eyes to determine whether the natural plant-based gauze provides additional microbiological benefits beyond mechanical eyelid cleansing alone. Safety and participant comfort will also be assessed.
Conditions
- Blepharitis
Interventions
- DEVICE
-
Plant-Based Sterile Eyelid Gauze
Participants received eyelid hygiene using Leniben® Gauze, a sterile single-use cotton gauze impregnated with a solution containing sodium hyaluronate, Echinacea angustifolia extract, Ananas sativus extract (bromelain), ammonium glycyrrhizate, and tocopherol. One eye of each participant was randomly assigned to the intervention. The upper and lower eyelid margins were cleansed using five standardized strokes, and microbiological samples were collected before treatment and 20 minutes after application to evaluate changes in bacterial colonization.
- DEVICE
-
Sterile Cotton Gauze Moistened with Saline Solution
Participants received eyelid hygiene using an identical sterile single-use cotton gauze moistened with sterile saline solution, without active ingredients. The contralateral eye of each participant was randomly assigned to the control treatment. The upper and lower eyelid margins were cleansed using the same standardized procedure as the experimental arm (five standardized strokes). Microbiological samples were collected before treatment and 20 minutes after application to evaluate changes in bacterial colonization attributable to mechanical cleansing alone
Sponsors & Collaborators
-
Federico II University
collaborator OTHER -
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e Ruggi D'Aragona
lead OTHER
Principal Investigators
-
Mario Troisi, MD · Azienda Ospedaliera Universitaria OO.RR. S. Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-02
- Primary Completion
- 2025-11-26
- Completion
- 2025-12-12
Countries
- Italy
Study Locations
More Related Trials
-
Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine
NCT04981860 ·Status: SUSPENDED ·Phase: PHASE4
-
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
NCT00518089 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
NCT02079649 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
NCT01363700 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis
NCT01740388 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Volunteers
NCT01744704 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
NCT01732757 ·Status: COMPLETED ·Phase: PHASE4
-
CHARACTERIZATION OF THE OCULAR SURFACE MICROBIOME IN THE REGION OF EPIRUS AND MACEDONIA (GREECE)
NCT07643077 ·Status: ACTIVE_NOT_RECRUITING
-
A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis
NCT00509873 ·Status: COMPLETED ·Phase: PHASE3
-
LEV102 Topical Gel in Acquired Blepharoptosis
NCT05715346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
NCT02161146 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
NCT00423007 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
NCT02436759 ·Status: COMPLETED ·Phase: PHASE3
-
Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation
NCT00905762 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
NCT00424398 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
NCT01470118 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Sirolimus in COVID-19 Infection
NCT04461340 ·Status: UNKNOWN ·Phase: PHASE2
-
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
NCT02531152 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
NCT05579730 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study
NCT04896125 ·Status: UNKNOWN
-
Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment
NCT04776096 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
NCT00241319 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine
NCT01179412 ·Status: COMPLETED ·Phase: PHASE4
-
Blephacura Versus Baby Shampoo to Treat Blepharitis
NCT01115192 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
NCT01287338 ·Status: TERMINATED ·Phase: PHASE2